Viewing StudyNCT00128843



Ignite Creation Date: 2024-05-05 @ 11:45 AM
Last Modification Date: 2024-10-26 @ 9:13 AM
Study NCT ID: NCT00128843
Status: COMPLETED
Last Update Posted: 2023-03-06
First Post: 2005-08-09

Brief Title: Exemestane Versus Anastrozole as First Line Hormone Therapy in Postmenopausal Metastatic Breast Cancer Patients
Sponsor: Spanish Breast Cancer Research Group
Organization: Spanish Breast Cancer Research Group

Conditions & Keywords Data

Conditions:
Name
Breast Cancer
Keywords:
Name View
Positive hormone receptor tumours View
Metastatic breast cancer View
First line of hormone treatment View
Postmenopausal women View